Exosens Full Year 2024 Earnings: EPS: €0.61 (vs €0.24 in FY 2023)

Exosens (EPA:EXENS) Full Year 2024 Results

Key Financial Results

• Revenue: €394.1m (up 35% from FY 2023).
• Net income: €25.5m (up 247% from FY 2023).
• Profit margin: 6.5% (up from 2.5% in FY 2023). The increase in margin was driven by higher revenue.
• EPS: €0.61 (up from €0.24 in FY 2023).

We've discovered 1 warning sign about Exosens. View them for free.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Exosens Earnings Insights

The primary driver behind last 12 months revenue was the Amplification segment contributing a total revenue of €280.2m (71% of total revenue). The largest operating expense was General & Administrative costs, amounting to €112.5m (55% of total expenses). Explore how EXENS's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 9.5% growth forecast for the Aerospace & Defense industry in France.

Performance of the French Aerospace & Defense industry.

The company's shares are up 7.6% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Exosens has 1 warning sign we think you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.